RBC Capital Raised Elevance Health (NYSE:ELV) target price to $572.00

By / / Elevance, Royal Bank of Canada

RBC Capital analyst Ben Hendrix upgrades Elevance Health (NYSE:ELV) from Sector Perform to Outperform and raises the price target from $523 to $572.

Scroll to Top